Medicated gauze
The present invention relates to a medicated gauze containing as active ingredient, aliantoin, a Centella asiatica extract and, optionally, an Urtica dioica extract.
1. A composition in the form of an ointment for treating cutaneous lesions comprising a mixture of principles in combination with dermatologically compatible excipients, wherein said active principles consist essentially of a Centella asiatica extract containing at least 4% by weight of total triterpenic fraction, an Urtica dioica extract containing at least 0.3% by weight of total sterols and allantoin, and wherein said extracts are dry extracts and wherein the dry extract of Centella asiatica is from 0.05% to 0.2% by weight, the dry extract of Urtica dioica is from 0.01% to 0.03% by weight and allantoin is from 0.4% to 1.6% by weight.
2. The composition according to claim 1 , wherein said Centella asiatica extract contains 4% by weight of total triterpenic fraction.
3. The composition according to claim 1 , wherein said Urtica dioica extract contains 0.4% by weight of total sterols.
4. The composition according to claim 1 further comprising polyethylene glycols.
5. The composition according to claim 4 , wherein said polyethylene glycols are a mixture of polyethylene glycols having molecular weights of 400, 1500 and 4000 Da.
6. A sterile medicated gauze uniformly impregnated with the composition according to claim 1 .
7. The sterile medicated gauze according to claim 6 , made of hydrophilic cotton.
8. The sterile medicated gauze according to claim 6 , impregnated with an amount of said ointment comprised between 0.03 and 0.05 g per cm 2 .
9. The sterile medicated gauze according to claim 8 wherein said amount of ointment is 0.04 g per cm 2 .
10. A method for topical treatment of cutaneous lesions comprising administering to a patient in need thereof an effective amount of the composition according to claim 1 .
11. The method according to claim 10 , wherein said cutaneous lesions are chronic cutaneous lesions.
12. The method according to claim 10 , wherein said cutaneous lesions are ulcero-dystrophic alterations (varicose ulcers, decubitus sores, torpid sores, fistula tracts, rhagades etc.) burns, lesiions resulting from delayed post-operative cicatrization and abrasions.